Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sangart has received $1.1m grant from the US Department of Defense to support the development of its new product platform based on the MP4 molecule.
Subscribe to our email newsletter
MP4 molecule is an investigational biopharmaceutical product designed to enhance the perfusion and oxygenation of oxygen-deprived tissues and provide targeted oxygen delivery to the capillaries in severely injured trauma patients.
Sangart is expected to utilise the fund for further pre-clinical development of the MP4 molecule in traumatic hemorrhage and ischemia in support of its current and future clinical programs.
Sangart president and CEO Brian O’Callaghan said that the grant supports their efforts in continuing the development of medicines designed to enhance the delivery of oxygen to tissues and organs that are oxygen deprived.